Orap

Orap is a brand name of pimozide, approved by the FDA in the following formulation(s):

ORAP (pimozide - tablet; oral)

• 
  Manufacturer: TEVA
  
  Approval date: July 31, 1984
  
  Strength(s): 2MG ^[RLD]


• 
  Manufacturer: TEVA
  
  Approval date: August 27, 1997
  
  Strength(s): 1MG
  

Has a generic version of Orap been approved?

No. There is currently no therapeutically equivalent version of Orap available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Orap. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Orap.

See also...

• Orap Consumer Information (Wolters Kluwer)
• Orap Consumer Information (Cerner Multum)
• Orap Advanced Consumer Information (Micromedex)
• Orap AHFS DI Monographs (ASHP)
• Pimozide Consumer Information (Wolters Kluwer)
• Pimozide Consumer Information (Cerner Multum)
• Pimozide Advanced Consumer Information (Micromedex)
• Pimozide AHFS DI Monographs (ASHP)